BioNTech SE (BNTX)
96.96
+4.90
(+5.32%)
USD |
NASDAQ |
Oct 09, 16:00
97.72
+0.76
(+0.79%)
Pre-Market: 08:36
BioNTech Free Cash Flow (Quarterly) : -52.17M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.17M |
| March 31, 2026 | -584.85M |
| December 31, 2025 | 277.00M |
| September 30, 2025 | 784.36M |
| June 30, 2025 | 700.63M |
| March 31, 2025 | -1.472B |
| December 31, 2024 | -601.69M |
| September 30, 2024 | -778.73M |
| June 30, 2024 | 1.607B |
| March 31, 2024 | -492.97M |
| December 31, 2023 | 1.143B |
| September 30, 2023 | 732.32M |
| June 30, 2023 | 4.400B |
| Date | Value |
|---|---|
| March 31, 2023 | -775.31M |
| December 31, 2022 | 442.74M |
| September 30, 2022 | 4.760B |
| June 30, 2022 | 4.104B |
| March 31, 2022 | 4.475B |
| December 31, 2021 | -313.07M |
| September 30, 2021 | 1.751B |
| June 30, 2021 | -156.95M |
| March 31, 2021 | -410.13M |
| December 31, 2020 | 231.66M |
| September 30, 2020 | -239.87M |
| June 30, 2020 | -35.53M |
| March 31, 2020 | -69.52M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | -563.00M |
| Mereo BioPharma Group Plc | -6.049M |
| NuCana Plc | -2.616M |
| Immatics NV | -71.00M |